Evaluating the prevalence and severity of NAFLD in primary care: the EPSONIP study protocol.
Patrik NasrFredrik IredahlNils DahlströmKarin RådholmPontus HenrikssonGunnar CedersundOlof Dahlqvist LeinhardTino EbbersJoakim AlfredssonCarl-Johan CarlhällPeter LundbergStergios KechagiasMattias EkstedtPublished in: BMC gastroenterology (2021)
Clinicaltrials.gov, identifier NCT03864510. Registered 6 March 2019, https://clinicaltrials.gov/ct2/show/NCT03864510 .